Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials

BACKGROUND. The prognostic significance of baseline contrast enhancing tumor prior to second- or third-line therapy in recurrent glioblastoma (GBM) for overall survival (OS) remains controversial, particularly in the context of repeated surgical resection and/or use of anti-angiogenic therapy. In th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Ellingson, Benjamin M., Harris, Robert J., Woodworth, Davis C., Leu, Kevin, Zaw, Okkar, Mason, Warren P., Sahebjam, Solmaz, Abrey, Lauren E., Aftab, Dana T., Schwab, Gisela M., Hessel, Colin, Lai, Albert, Nghiemphu, Phioanh L., Pope, Whitney B., Wen, Patrick Y., Cloughesy, Timothy F.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Clinical Investigations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193027/
https://ncbi.nlm.nih.gov/pubmed/27580889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now187
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker